FLT3-ITD mutation in the JM domain causes constitutive activation of tyrosine kinases, leading to autophosphorylation of the receptors and subsequent activation of downstream signaling pathways such as signal transducers and activators of transcription 5 (STAT5), ultimately facilitating the progression of leukemia [16,19,20]. This evidence concerns the gene FLT3 and leukemia.